The agency says the safety concern is unlikely to represent a true risk and is still recommending that people stay up-to-date with boosters

The US Centers for Disease Control and Prevention on Friday said there is a possible safety issue with the bivalent Covid-19 vaccine made by Pfizer and BioNTech, but it’s unlikely it represents a true risk. The agency said it continues to recommend people stay up-to-date with Covid-19 vaccines.